Keyword: R&D

Chemistry & Life Sciences

'Always Solving' - Ashland Launches New Brand

19.11.2016 - Ashland is a specialty chemicals company serving customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction...

Strategy & Management

At the Crossroads of Technology and Information

09.11.2016 - With the FDA approving the first 3D printed drug in 2016, emerging technologies are having a significant effect on the pharmaceutical industry. And it’s not just on the patient...

News

Valeant Selling Salix to Takeda?

03.11.2016 - Valeant Pharmaceuticals is in advanced discussions with Japan’s Takeda to sell its Salix subsidiary for $10 billion, according to the US business newspaper Wall Street Journal. The...

News

Merck and Pfizer in Lung Pact With Debiopharm

25.10.2016 - Major drugmakers Merck KGaA of Germany and Pfizer of the US are collaborating with Debiopharm International, a drug developer based in Lausanne, Switzerland to study the potential...

News

Novartis Axes Swiss and Chinese R&D Sites

10.10.2016 - As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...

News

Cambrex Validates Milan API Pilot Plant

05.10.2016 - US life sciences company Cambrex has completed and validated a new pilot plant at its manufacturing and R&D site in Paullo, Milan, Italy. Built to meet customer demand for small...

News

Sibur Upgrades Tomsk Polymer Production

27.09.2016 - Russian gas and petrochemicals giant Sibur has upgraded and expanded its polymer production at Tomsk. Sums totalling more than 10 billion rubles ($157 million) have been spent on...

Trends in Chemical & Pharmaceutical Research

26.09.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...